Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
Sept 26 (Reuters) - Unilever CEO Alan Jope plans to retire at the end of 2023 roughly two months after activist investor Nelson Peltz joined the board of the consumer goods company.
Read moreSept 26 (Reuters) - Unilever CEO Alan Jope plans to retire at the end of 2023 roughly two months after activist investor Nelson Peltz joined the board of the consumer goods company.
Read moreCEO Jope to retire at end 2023
*Read more(Alliance News) - Unilever PLC on Monday said Chief Executive Alan Jope will step down at the end of next year, after five years in the post.
Read more(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire.
Read more(Sharecast News) - GSK has named Burberry Group's Julie Brown as its new chief financial officer.
Read more(Alliance News) - All eyes will be on the pound when traders in Europe return to desks on Monday, after the UK currency fell to an all-time low during the Asian session.
Read moreSept 24 (Reuters) - British drugmaker GSK plc has poached Burberry Group's finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday.
Read moreSept 24 (Reuters) - British drugmaker GSK plc, has poached Burberry Group's finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday.
Read more(Alliance News) - GSK PLC on Thursday said its cancer drug Zejula will be reviewed by the US Food & Drug Administration for overall survival data for patients with ovarian cancer.
Read more(Alliance News) - GSK PLC on Thursday said it has signed an exclusive licence agreement with Massachusetts-based biotechnology firm Spero Therapeutics for the latter's tebipenem pivoxil hydrobromide, or tebipenem HBr.
Read more(Sharecast News) - UK pharmaceutical company GSK is taking a stake in Spero Therapeutics as part of a licensing agreement for the US-based drug developer's experimental antibiotic for complicated urinary tract infections.
Read more(Alliance News) - The following is a summary of top news stories Tuesday.
Read more(Alliance News) - Haleon PLC on Tuesday reported a strong performance in the first half of 2022 in its first earnings report since being split from GSK PLC in July and separately listed, noting double-digit revenue growth and profit rise.
Read moreLONDON, Sept 20 (Reuters) - Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company's CEO Brian McNamara told Reuters on Tuesday.
Read more(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II.
Read more